 |
 |
 |
 |
The existence of heterogeneity in tumors at the genetic, phenotypic, and
morphologic levels has been appreciated for a number of years. While
fundamental research into the causes and appropriate treatment of human
cancers is now advancing rapidly, translation of these findings into
clinical practice is hampered by a number of issues. Of the current
technologies used to study cancer, cytometry is unique in that it allows
quantitative measurements on a single cell level which can best describe
heterogeneous populations. However, the cytometry community at present
has an incomplete grasp of the problems associated with studies of
cellular heterogeneity.
This meeting will be structured around small working groups composed of
individuals with expertise in the fields of: DNA ploidy analysis and
cancer genetics; cellular proliferation, differentiation, and death;
cytotoxic drug resistance; hematopathology and hematology; and,
mathematical modeling and statistical analysis of heterogeneous
populations. The format of this symposium is intended to stimulate
intense interactions among attendees, with the intention of producing
recommendations for future developments in this field. There will be no
formal lecture style presentations at this symposium.
Space is limited to roughly 120 attendees, with the need for a balanced
representation of individuals with expertise in the above mentioned
areas. Those wishinging to attend are requested to send a letter of
application (deadline Jan. 15, 1995), including a brief statement of
their interests, expectations from this symposium, and the contributions
that could be made by their participation. There is no registration fee,
though attendees are required to pay $500 (US) in advance, to cover the
costs of four nights shared accommodation plus meals. Send letters of
application to:
David Hedley
Department of Medicine
Princess Margaret Hospital
500 Sherebourne St.
Toronto, Ontario M4X 1K9
Canada
FAX 416-926-6546
e-mail 70740.1375@compuserve.com
|
|
|
|